Other Briefings
Thailand Issues First Personal Data Protection Act
Thailand’s first-ever law on personal data protection will come into force on June 1, 2022, after being postponed since 2019.
Cambodia’s First Law on Competition: What Investors Need to Know
In October 2021, Cambodia’s Law on Competition came into effect, marking the country’s first-ever anti-trust law following 15 years of deliberations and delays.
Malaysia’s Border Reopening: Boost for Tourism Sector, Hiring in Palm Oil Industry
We discuss how Malaysia’s border reopening will benefit the tourism and palm oil production industries and list the updated entry requirements.
The Philippines’ Border Reopening: Implications for Businesses
The Philippines tourism industry is set to benefit from ease in border restrictions as the country is now open to fully vaccinated international travelers.
Thailand Flexible Plus Program: Attracting High-Net-Worth Investors
The program is only open to Thailand Privilege Card members, and offers international investors the ability to convert their privilege entry visa into a non-immigrant (B) visa.
Thailand Issues Tax Incentives for Investments in Local Startups
We list the eligibility criteria, targeted industries, and tax incentives available for entities or individuals making investments into Thai startups.
Indonesia Bans the Export of Palm Oil, Impacting Global Food Prices
As of April 28, 2022, Indonesia has begun a complete ban on palm oil exports, a move that could threaten global food prices.
Assessing the Current Human Resources Talent Pool in ASEAN
ASEAN is endowed with a diverse workforce but these are spread across different levels of the developmental spectrum.
HDB Green Towns: Supporting Singapore’s Sustainable Development Goals
Singapore’s HDB Green Town program has an overarching goal of reducing annual energy consumption by public estates by 15 percent by 2030.
Tax Incentives for Pharmaceutical Manufacturers in Malaysia: How Can Businesses Qualify?
Malaysia will continue to accept applications for tax incentives from pharmaceutical manufacturers until December 31, 2022.
